Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Recruiting now · Phase 1/Phase 2
Conditions studied: Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications, Integumentary Disease, Musculoskeletal Disorders, Neurodegenerative Disorders, Neurologic Disorders, Pulmonary Disorders, Sexual Dysfunction, Urologic Disorders, Viral Illness
In brief
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Key facts
- Study ID
- NCT04684602
- Run by
- Thomas Advanced Medical LLC
- People needed
- 5000
- Starts
- 2020-07-09
- Expected to finish
- 2030-12-09
- Last updated by the study team
- 2022-04-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 and older
- Ability to provide informed consent
- Availability for follow up visits
You may not qualify if…
- Active or recent malignancy (within last 2 years)
- Pregnancy or breast-feeding
- Inability to provide informed consent
Where it is running
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites — Culver City, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.